Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. - Hermansen,K.; Kipnes,M.; Luo,E. (Diabetes Obes Metab, 2007)